Source: CLINICAL AND EXPERIMENTAL DERMATOLOGY. Unidade: FM
Subjects: ANTIMALÁRICOS, FARMACOTERAPIA, ALOPECIA, RESULTADO DE TRATAMENTO
ABNT
SOARES, Isabella Ibrahim Doche et al. Hydroxychloroquine may be beneficial as an adjuvant therapy for folliculitis decalvans: a 5-year retrospective study with 49 patients. CLINICAL AND EXPERIMENTAL DERMATOLOGY, v. 50, n. 2, p. 404-407, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/82908. Acesso em: 24 jan. 2026.APA
Soares, I. I. D., Sotto, M. N., Hordinsky, M. K., Melhado, I. P., Gerlero, P., & Machado, M. C. da M. R. (2024). Hydroxychloroquine may be beneficial as an adjuvant therapy for folliculitis decalvans: a 5-year retrospective study with 49 patients. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 50( 2), 404-407. doi:10.1093/ced/llae394NLM
Soares IID, Sotto MN, Hordinsky MK, Melhado IP, Gerlero P, Machado MC da MR. Hydroxychloroquine may be beneficial as an adjuvant therapy for folliculitis decalvans: a 5-year retrospective study with 49 patients [Internet]. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2024 ; 50( 2): 404-407.[citado 2026 jan. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/82908Vancouver
Soares IID, Sotto MN, Hordinsky MK, Melhado IP, Gerlero P, Machado MC da MR. Hydroxychloroquine may be beneficial as an adjuvant therapy for folliculitis decalvans: a 5-year retrospective study with 49 patients [Internet]. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2024 ; 50( 2): 404-407.[citado 2026 jan. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/82908
